Smart Insulin Technology — A Promising Intuitive Automated Diabetic Care Solution
From a patient’s perspective, those suffering from both type 1 and type 2 diabetes need to take care of their own medication schedule, dosages, as well a
Aranca's research experience in the pharmaceutical sector spans several segments like pharmacology, pharamaceutics, medicinal chemistry, pharmacognosy (herbal drugs), biochemistry, bio-pharamaceutics and veterinary medicines.
We support several global pharma companies, law firms, universities and technology transfer firms with novelty, freedom-to-operate, invalidation and landscape studies for new chemical entities, drug molecules, formulations or compositions and other niche areas such as chemical structure, traditional knowledge search and drug report preparation i.e. orange book analysis, clinical trial information and analysis of FDA data.
Projects conducted.
Pharmaceutical technologies covered by our consultants.
Clients including Pharma and Biotech companies.
Man hours of research experience.
Significant breadth and depth of experience across the Pharmaceutical domain.
R&D Strategy Roadmaps
White Space Analysis
Technology Landscape | Innovation Focus
Monetizing Existing Technical Know-how
Technology Scouting and Acquisition
Product Design for Emerging Technologies/ Markets
Prosecution Support
Prior Art Searches
Portfolio Analysis
Technology/ Patent Landscape
Clinical Trial Study Support
Drug Approval and Patent Expiry Study Support
Looking for help with Technology Intelligence, IP Strategy, or Litigation support?
From a patient’s perspective, those suffering from both type 1 and type 2 diabetes need to take care of their own medication schedule, dosages, as well a
The digitization of data and processes across the value chain coupled with the Internet of Things (IoT) could transform the pharmaceutical industry. Besides healthcare
Testing new drugs and therapies on 3D-printed human organs in a lab could reduce the time and costs of getting a new drug to market
The new healthcare ecosystem is increasingly becoming “patient-centric”. With the “one-drug-for-all” approach rapidly being replaced by personalized treatment, pharmaceutical companies are scouting for technology enablers to real
While the number of IPOs in the US decreased from 275 in 2014 to 105 in 2016, the US IPO market has rebounded in 1H2017. The rebound can be
If you're in business, you're at war.Odds are you’re also trying to run a lean business, which means you've not got enough manpower t
The animal healthcare market in France is on the upswing, boosted by growing disposable income, a rising number of pets, as well as growing awareness
A growing demand for frozen foods as well as better business models will bolster growth for the global refrigerated transport market.
One of the main reasons driving the growth of the telemedicine market in the US is the growth in the number of computing devices coupled
Patents are the undisputable kingmakers in the life sciences industry. Pharmaceutical giants who enjoyed a fruitful run while their branded drugs brought in billions have
Change is inevitable. Thus, the urban metro-sexual man does not shy away from spending time and money on grooming, which therefore brings a great opportunity
Over the past decade, 3D printing has been blurring boundaries between imagination and fabrication.
With deals likely to be at their highest since 2005, the pharmaceuticals sector can look forward to a thriving 2015.
About Us
Services
Knowledge Library
Contact Us
© , Aranca. All rights reserved.
United States | United Kingdom | China | India | Dubai | KSA | Japan